Liu Hai-lin, Li Xiang-cheng, Qiang Yan-ning
Department of Anesthesiology, the 1st Hospital of Huai'an, Affiliated Hospital of Nanjing Medical University, Huai'an 223300, China.
Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2011 Aug;27(3):343-7.
To explore the effects of intrathecal injection of mitogen-activated protein kinases inhibitors U0126 on the behavioral changes of morphine-induced dependent and withdrawal rats and the expression of nitric oxide synthase (NOS) in spinal cord.
All the rats were divided into 4 groups: control group, dependent group, withdrawal group, U0126 group (5 microg). Global withdrawal score, Touch evoked agitation scores (TEA score), immunohistochemical and Western blot technique were undertaken to evaluate behavioral changes and expression of FOS, nNOS and iNOS in spinal cord respectively.
The results showed that intrathecal administration of U0126 significantly alleviated withdrawal symptom, withdrawal scores of U0126 group (22.5 +/- 4.09) were significantly lower than than those of withdrawal group (28.6 +/- 4.89) (P < 0.05). TEA scores of withdrawal group were 13.5 +/- 2.55, which were significantly higher than those of U0126 group (10.0 +/- 2.76, P < 0.05). Fos-like positive neurons in dorsal horn of withdrawal group were 380 +/- 71, which were higher than those of U0126 group(287 +/- 54, P < 0.05). Also nNOS and iNOS positive neurons in dorsal horn of U0126 group were 180 +/- 32, 10.8 +/- 2.8 respectively, which were significantly lower than that of withdrawal group (239 +/- 45, 16.8 +/- 5.1, P < 0.05). Compared with withdrawal group, levels of nNOS and iNOS protein in spinal cord of U0126 group were significantly lower.
MEK inhibitors could alleviate withdrawal symptom of morphine-induced dependent rats and could suppress expression of NOS in spinal cord, and extracellular signal-regulate kinase (ERK) might involve the expression of NOS in spinal cord.
探讨鞘内注射丝裂原活化蛋白激酶抑制剂U0126对吗啡诱导的依赖及戒断大鼠行为变化及脊髓中一氧化氮合酶(NOS)表达的影响。
将所有大鼠分为4组:对照组、依赖组、戒断组、U0126组(5微克)。采用整体戒断评分、触诱发激惹评分(TEA评分)、免疫组织化学和蛋白质印迹技术分别评估行为变化及脊髓中FOS、nNOS和iNOS的表达。
结果显示,鞘内注射U0126可显著减轻戒断症状,U0126组的戒断评分(22.5±4.09)显著低于戒断组(28.6±4.89)(P<0.05)。戒断组的TEA评分为13.5±2.55,显著高于U0126组(10.0±2.76,P<0.05)。戒断组脊髓背角Fos样阳性神经元为380±71,高于U0126组(287±54,P<0.05)。U0126组脊髓背角nNOS和iNOS阳性神经元分别为180±32、10.8±2.8,显著低于戒断组(239±45、16.8±5.1,P<0.05)。与戒断组相比,U0126组脊髓中nNOS和iNOS蛋白水平显著降低。
MEK抑制剂可减轻吗啡诱导的依赖大鼠的戒断症状,并可抑制脊髓中NOS的表达,细胞外信号调节激酶(ERK)可能参与脊髓中NOS的表达。